A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
Arkansas has become the first US state in 17 years to carry out back-to-back executions after putting two inmates to death.
Up to three million children risk going hungry over the school holidays, with increasing numbers of families relying on food banks, MPs say.
Tuesday will be a cold and windy day across the British Isles with a mix of sunshine and showers.